SCHEMBL28524732

SCHEMBL28524732

CN(CCN1CCC(c2cccc(-c3ccccc3)c2NC(=O)O)CC1)C(=O)c1ccc(CCl)cc1

nearest known ligand 0.51

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 1/20 0.51
▸ ACHE P22303 1/20 0.41
▸ ADRB2 P07550 1/20 0.40
▸ CHRM3 P20309 1/20 0.40
▸ HRH3 Q9Y5N1 2/20 0.40
▸ OPRD1 P41143 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ MCHR1 Q99705 2/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28521336 0.92 CHRM2 (0.49) CHRM2ACHEADRB2CHRM3HRH3
SCHEMBL28953805 0.89 CHRM2 (0.67) CHRM2ACHEOPRD1KCNH2MCHR1
SCHEMBL768111 0.84 CHRM2 (0.43) CHRM2ACHEADRB2CHRM3HRH3
SCHEMBL768818 0.83 CHRM2 (0.42) CHRM2ACHEADRB2CHRM3HRH3
SCHEMBL769143 0.80 CHRM2 (0.40) CHRM2ADRB2CHRM3HRH3OPRD1
SCHEMBL768953 0.80 HRH3 (0.42) CHRM2CHRM3HRH3KCNH2
SCHEMBL768533 0.79 HRH3 (0.41) CHRM2CHRM3HRH3KCNH2
SCHEMBL769138 0.79 HRH3 (0.41) CHRM2CHRM3HRH3KCNH2
SCHEMBL767767 0.79 HRH3 (0.41) CHRM2CHRM3HRH3KCNH2
SCHEMBL768439 0.79 CHRM2 (0.39) CHRM2ADRB2CHRM3HRH3MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116514704-B Rafenacin intermediate and preparation method thereof 北京远大九和药业有限公司 2023-09-29 — — CN disclosed
CN-116514704-A Rafenacin intermediate and preparation method thereof 北京远大九和药业有限公司 2023-08-01 — — CN disclosed
CN-110526859-B Revinanexin intermediate, preparation method thereof and preparation method of Revinanexin 山东百诺医药股份有限公司 2021-03-12 — — CN disclosed
Send feedback